A federal judicial panel has created a new multidistrict litigation (MDL) in Pennsylvania to centralize lawsuits alleging that GLP-1 weight-loss drugs caused vision loss, including NAION , placing the cases before Judge Karen Marston
Our modern 20,000-square-meter facility with 100,000-level purification workshops, SGS-standardized laboratories, and annual production capacity of 3,000 tons ensures consistent supply and quality excellence
Your provider can adjust dosing, pause treatment, or refer you to specialist care
Share Share Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars
To get well, you need a mix of [] The post Understanding Opioid Drug Addiction: Why Brain Chemistry Makes Quitting Hard appeared first on Virtue Recovery Las Vegas
Stigma has been widely reported as a major obstacle for initiation onto existing treatments for SUD and for transitioning long term pain patients from oxycodone to buprenorphine